The effect of silver nanoparticles (AgNPs) on proliferation and apoptosis of in ovo cultured glioblastoma multiforme (GBM) cells

Abstract

Recently, it has been shown that silver nanoparticles (AgNPs) provide a unique approach to the treatment of tumors, especially those of neuroepithelial origin. Thus, the aim of this study was to evaluate the impact of AgNPs on proliferation and activation of the intrinsic apoptotic pathway of glioblastoma multiforme (GBM) cells cultured in an in ovo model. Human GBM cells, line U-87, were placed on chicken embryo chorioallantoic membrane. After 8 days, the tumors were divided into three groups: control (non-treated), treated with colloidal AgNPs (40 μg/ml), and placebo (tumors supplemented with vehicle only). At the end of the experiment, all tumors were isolated. Assessment of cell proliferation and cell apoptosis was estimated by histological, immunohistochemical, and Western blot analyses. The results show that AgNPs can influence GBM growth. AgNPs inhibit proliferation of GBM cells and seem to have proapoptotic properties. Although there were statistically significant differences between control and AgNP groups in the AI and the levels of active caspase 9 and active caspase 3, the level of these proteins in GBM cells treated with AgNPs seems to be on the border between the spontaneous apoptosis and the induced. Our results indicate that the antiproliferative properties of silver nanoparticles overwhelm proapoptotic ones. Further research focused on the cytotoxic effect of AgNPs on tumor and normal cells should be conducted.Electronic supplementary materialThe online version of this article (doi:10.1186/s11671-015-0823-5) contains supplementary material, which is available to authorized users.

Mechanistic Basis of Antimicrobial Actions of Silver Nanoparticles

“…However, the cytotoxic, genotoxic, apoptotic and anti-proliferative effect of AgNPs can be used as a strategy against cancerous cells, such as cancer treatment of GBM patients (Gopinath et al, 2008; Urbańska et al, 2015). In this perspective, to encourage the safe use of AgNPs in disease therapy, long-term cytotoxicity, mutagenicity and carcinogenicity studies should be conducted in order to verify any adverse effects that may occurs during their use in therapeutics and drug delivery (Becker et al, 2011; Maneewattanapinyo et al, 2011; Klien and Godnic-Cvar, 2012; Tran et al, 2013).…”

Tannic acid-modified silver nanoparticles as a novel therapeutic agent against Acanthamoeba

“…AgTANPs were prepared by mixing the heated aqueous solution of AgNO 3 (95.2 g, 0.017%) with the aqueous solution of tannic acid (0.6 g, 5% C 76 H 52 O 46 Sigma-Aldrich). The long-term stability of the colloidal dispersions of all tested NPs (zeta potential) was measured and confirmed by the electrophoretic lightscattering method with a Zetasizer Nano ZS, model ZEN3500 (Malvern Instruments, Worcestershire, UK) (Orlowski et al 2014;Urbańska et al 2015;Zielinska et al 2011).…”

Doxorubicin Conjugated to Glutathione Stabilized Gold Nanoparticles (Au-GSH-Dox) as an Effective Therapeutic Agent for Feline Injection-Site Sarcomas—Chick Embryo Chorioallantoic Membrane Study

“…Despite its obvious limitations compared to in vivo studies on rodent models (e.g., the impossibility to perform pharmacokinetic studies) it is a good model for general anticancer compound screening because it allows for a reduction in the number of animals used for further in vivo studies according to 3R rule. It may therefore be used as an intermediate model between in vitro and in vivo studies [ 5 , 10 , 11 , 12 , 13 , 14 ]. It has been successfully used for assessing tumour progression [ 13 ], cancer cell invasion and metastasis [ 11 , 12 , 15 ], pro- and antiangiogenic drug response [ 16 ], vascular effects of photodynamic therapy [ 17 ], toxicological and efficiency studies on anticancer drugs [ 13 , 18 , 19 , 20 , 21 ].…”